Healthy Individuals for Hip Injury

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Hip Injury+1 MorePhysical Therapy - Procedure
Eligibility
14 - 22
All Sexes
What conditions do you have?
Select

Study Summary

This study will utilize the Moxy wearable sensor to measure muscle oxygen saturation levels in athletes following lower extremity surgery (ACL or Hip arthroscopy) to evaluate their Return-to-Play. The acquired data will complement current protocols utilized by Dr. Voos and Dr. Salata in this regard and will add quantifiable evidence to enable a robust measurement of the surgical limb versus non-surgical limb.

Eligible Conditions
  • Anterior Cruciate Ligament Injury
  • Hip Injury

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 6 weeks, 12 weeks, 6 months, 9 months (once for healthy individuals)

Month 9
Change in O2 Saturation levels as measured by Moxy Sensor device
Changes in hemoglobin levels as measured by Moxy Sensor device

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Healthy Individuals
1 of 2
Surgical Patients
1 of 2

Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Healthy Individuals · No Placebo Group · N/A

Healthy IndividualsExperimental Group · 2 Interventions: Monitored Work-out, Moxy Oxygen Sensor Device · Intervention Types: Procedure, Device
Surgical PatientsExperimental Group · 2 Interventions: Physical Therapy, Moxy Oxygen Sensor Device · Intervention Types: Procedure, Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical Therapy
2020
Completed Phase 4
~1330

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 weeks, 12 weeks, 6 months, 9 months (once for healthy individuals)

Who is running the clinical trial?

University Hospitals Cleveland Medical CenterLead Sponsor
300 Previous Clinical Trials
337,560 Total Patients Enrolled
James Voos, MDPrincipal InvestigatorUniversity Hospitals Cleveland Medical Center
Sunita Mengers, MDStudy DirectorUniversity Hospitals Cleveland Medical Center

Eligibility Criteria

Age 14 - 22 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are eligible for this study if you are age 14 to 22 years.